These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 13140897)

  • 1. [Lysogenic variants of R Brx colibacillus; characteristics of symbiosis in phage-bacteria systems and in phago-resistant forms of variation arising in complex conditions in 172 entire microbe populations combined].
    CIUCA M; RUSS S; PAUNESCU E; BADENSKI A; MACARIE I
    Bul Stiint Sect Stiint Medicale Acad Republicii Pop Romane; 1953; 5(1):15-59. PubMed ID: 13140897
    [No Abstract]   [Full Text] [Related]  

  • 2. [HPOX effect on complexes formed by T2 phage with a lysogenic non-inducible bacteria (E. coli Lisbon P1,P2,P3-)].
    TETI M
    Riv Ist Sieroter Ital; 1954; 29(4):337-41. PubMed ID: 13216069
    [No Abstract]   [Full Text] [Related]  

  • 3. [Growth and development of bacteria and their relation to the phenomenon of bacteriophage. III. Symbiosis of organisme as a factor inducing bacterial phage production].
    PEKHOV AP
    Biull Eksp Biol Med; 1958 Feb; 45(2):87-9. PubMed ID: 13535849
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of formaldehyde-treated bacteriophage on sensitive Colibacillus].
    BOURGAUX P
    C R Seances Soc Biol Fil; 1957; 151(6):1267-9. PubMed ID: 13511888
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic differences between phage-susceptible and phage-resistant variants of a strain of Escherichia coli.
    SCHERP HW; COFFIN SF; WALDO JF
    J Bacteriol; 1947 Jul; 54(1):78. PubMed ID: 20255174
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interaction of RNA-containing bacteriophages with the host cells: MS2-induced E. coli mutants and formation of DNA-containing derivatives of MS2 bacteriophage].
    Pererva TP; Miriuta AIu; Miriuta NIu
    Tsitol Genet; 2008; 42(1):73-90. PubMed ID: 18411761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly identified bacteriophages carrying the stx2g Shiga toxin gene isolated from Escherichia coli strains in polluted waters.
    GarcĂ­a-Aljaro C; Muniesa M; Jofre J; Blanch AR
    FEMS Microbiol Lett; 2006 May; 258(1):127-35. PubMed ID: 16630267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enumeration of bacteriophages in water by different laboratories of the European Union in two interlaboratory comparison studies.
    Mooijman KA; Ghameshlou Z; Bahar M; Jofre J; Havelaar AH
    J Virol Methods; 2005 Jul; 127(1):60-8. PubMed ID: 15893567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage specificity and lipopolysaccarides of stem- and root-nodulating bacteria (Azorhizobium caulinodans, Sinorhizobium spp., and Rhizobium spp.) of Sesbania spp.
    Sharma RS; Mishra V; Mohmmed A; Babu CR
    Arch Microbiol; 2008 Apr; 189(4):411-8. PubMed ID: 17989956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors controlling aptitude and phage development in a lysogenic Escherichia coli K-12.
    BOREK E
    Biochim Biophys Acta; 1952 Feb; 8(2):211-5. PubMed ID: 14904491
    [No Abstract]   [Full Text] [Related]  

  • 11. Phage typing of indigenous soybean-rhizobia and relationship of a phage group strains for their asymbiotic and symbiotic nitrogen fixation.
    Appunu C; Dhar B
    Indian J Exp Biol; 2006 Dec; 44(12):1006-11. PubMed ID: 17176675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of genes of prophage P1 Escherichia coli in cells of phytopathogenic Erwinia].
    Burova LM; Tovkach FI
    Mikrobiol Z; 2006; 68(2):39-47. PubMed ID: 16786627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli TolA tolerates multiple amino-acid substitutions as revealed by screening randomized variants for membrane integrity and phage receptor function.
    Karlsson F; Malmborg-Hager AC; Borrebaeck CA
    FEMS Microbiol Lett; 2006 Jun; 259(1):81-8. PubMed ID: 16684106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental phage therapy in the beginning of the 21st century].
    Debarbieux L
    Med Mal Infect; 2008 Aug; 38(8):421-5. PubMed ID: 18692973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Examination of the natural variation in "transactive" phage resistant variants of producers of streptomycin].
    TETERIATNIK AF; ALIKHANIAN SI; OLENEVA ZG
    Antibiotiki; 1962 Oct; 7():859-63. PubMed ID: 13980766
    [No Abstract]   [Full Text] [Related]  

  • 16. [The cotransduction of pET system plasmids by mutants of T4 and RB43 bacteriophages].
    Tianiashin VI; Zimin VI; Boronin AM
    Mikrobiologiia; 2003; 72(6):785-91. PubMed ID: 14768546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward rational control of Escherichia coli O157:H7 by a phage cocktail.
    Tanji Y; Shimada T; Yoichi M; Miyanaga K; Hori K; Unno H
    Appl Microbiol Biotechnol; 2004 Apr; 64(2):270-4. PubMed ID: 13680205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models of phage growth and their applicability to phage therapy.
    Weld RJ; Butts C; Heinemann JA
    J Theor Biol; 2004 Mar; 227(1):1-11. PubMed ID: 14969703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on interference between virulent T2 phage and lambda phage lysogenically carried in E. coli, K12.
    KONISHI Y; ODA M
    Jpn J Exp Med; 1956 Apr; 26(1-2):1-8. PubMed ID: 13398180
    [No Abstract]   [Full Text] [Related]  

  • 20. [Remarks on the periodicity of infections by phage in Escherichia coli].
    MACCACARO GA; TURRI M
    Nuovi Ann Ig Microbiol; 1957; 8(5):536. PubMed ID: 13484124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.